EUVIMEDEUVIMED entdecken
Crossref

Beta-Blocker Use in Acquired Long QT Syndrome is Associated with Better Survival

Jan Hysing, Jacob Thalamus, Charlotte Gibbs, Øystein Lunde Holla, Keson Jaioun, Geir Hoff, Kristina H Haugaa

Journal of Pharmacy and Pharmacology Research · 2026

DOI: 10.26502/fjppr.0129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology Research, 2026. Verfasst von Jan Hysing und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hysing, J., Thalamus, J., Gibbs, C., Holla, Ø. L., Jaioun, K., Hoff, G., & Haugaa, K. H. (2026). Beta-Blocker Use in Acquired Long QT Syndrome is Associated with Better Survival. Journal of Pharmacy and Pharmacology Research. https://doi.org/10.26502/fjppr.0129

Vancouver

Hysing J, Thalamus J, Gibbs C, Holla ØL, Jaioun K, Hoff G, et al. Beta-Blocker Use in Acquired Long QT Syndrome is Associated with Better Survival. Journal of Pharmacy and Pharmacology Research. 2026. doi:10.26502/fjppr.0129

BibTeX
@article{Hysing2026,
  author = {Hysing, Jan and Thalamus, Jacob and Gibbs, Charlotte and Holla, Øystein Lunde and Jaioun, Keson and Hoff, Geir and Haugaa, Kristina H},
  title = {Beta-Blocker Use in Acquired Long QT Syndrome is Associated with Better Survival},
  journal = {Journal of Pharmacy and Pharmacology Research},
  year = {2026},
  doi = {10.26502/fjppr.0129}
}
Kostenlos starten →